245 related articles for article (PubMed ID: 16951932)
1. Costimulatory molecules as immunotherapeutic targets in systemic lupus erythematosus.
Foell J; Mittler RS
Springer Semin Immunopathol; 2006 Oct; 28(2):153-62. PubMed ID: 16951932
[TBL] [Abstract][Full Text] [Related]
2. T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunity.
Foell J; Hewes B; Mittler RS
Curr Cancer Drug Targets; 2007 Feb; 7(1):55-70. PubMed ID: 17305478
[TBL] [Abstract][Full Text] [Related]
3. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
4. Biologic response modifiers in acute lymphoblastic leukemia.
Gribben JG; Cardoso AA; Schultze JL; Nadler LM
Leukemia; 1997 May; 11 Suppl 4():S31-3. PubMed ID: 9179280
[TBL] [Abstract][Full Text] [Related]
5. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
Wells AD; Walsh MC; Bluestone JA; Turka LA
J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients.
Köller M; Zwölfer B; Steiner G; Smolen JS; Scheinecker C
Int Immunol; 2004 Nov; 16(11):1595-604. PubMed ID: 15381672
[TBL] [Abstract][Full Text] [Related]
7. T-cell tolerance or function is determined by combinatorial costimulatory signals.
Nurieva R; Thomas S; Nguyen T; Martin-Orozco N; Wang Y; Kaja MK; Yu XZ; Dong C
EMBO J; 2006 Jun; 25(11):2623-33. PubMed ID: 16724117
[TBL] [Abstract][Full Text] [Related]
8. Costimulation and its role in organ transplantation.
Bluestone JA
Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
[TBL] [Abstract][Full Text] [Related]
9. Dynamic regulation of T-cell costimulation through TCR-CD28 microclusters.
Yokosuka T; Saito T
Immunol Rev; 2009 May; 229(1):27-40. PubMed ID: 19426213
[TBL] [Abstract][Full Text] [Related]
10. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B; Bluestone JA
Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
[TBL] [Abstract][Full Text] [Related]
11. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
Moeller M; Haynes NM; Trapani JA; Teng MW; Jackson JT; Tanner JE; Cerutti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
Cancer Gene Ther; 2004 May; 11(5):371-9. PubMed ID: 15060573
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
Allen SD; Rawale SV; Whitacre CC; Kaumaya PT
J Pept Res; 2005 Jun; 65(6):591-604. PubMed ID: 15885118
[TBL] [Abstract][Full Text] [Related]
13. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
Chambers CA; Kuhns MS; Egen JG; Allison JP
Annu Rev Immunol; 2001; 19():565-94. PubMed ID: 11244047
[TBL] [Abstract][Full Text] [Related]
15. The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.
Mak A; Schwarz H
Cells; 2019 Sep; 8(9):. PubMed ID: 31500130
[TBL] [Abstract][Full Text] [Related]
16. Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein.
Blanco B; Holliger P; Alvarez-Vallina L
Cancer Gene Ther; 2002 Mar; 9(3):275-81. PubMed ID: 11896444
[TBL] [Abstract][Full Text] [Related]
17. T cells in the pathogenesis of systemic lupus erythematosus.
Hoffman RW
Clin Immunol; 2004 Oct; 113(1):4-13. PubMed ID: 15380523
[TBL] [Abstract][Full Text] [Related]
18. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals.
Meyaard L; Kuiper H; Otto SA; Wolthers KC; van Lier RA; Miedema F
Eur J Immunol; 1995 Jan; 25(1):232-7. PubMed ID: 7531146
[TBL] [Abstract][Full Text] [Related]
19. Topical inhibition of T cell costimulatory pathways in draining lymph nodes may suppress allograft rejection.
Li Y; Han Y; Xia W; Guo SZ
Med Hypotheses; 2011 Mar; 76(3):441-4. PubMed ID: 21134721
[TBL] [Abstract][Full Text] [Related]
20. CD28 costimulatory signals in T lymphocyte activation: Emerging functions beyond a qualitative and quantitative support to TCR signalling.
Porciello N; Tuosto L
Cytokine Growth Factor Rev; 2016 Apr; 28():11-9. PubMed ID: 26970725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
